6-MAPDB

From Wikipedia, the free encyclopedia
Jump to: navigation, search
6-MAPDB
6-MAPDB structure.png
Systematic (IUPAC) name
1-(2,3-dihydrobenzofuran-6-yl)-N-methylpropan-2-amine
Clinical data
Legal status
  • AU: Analogue of MDMA
  • CA: Analogue of amphetamine
  • UK: Temporary class drug
  • US: Analogue of MDMA
Identifiers
CAS number 1354631-81-4
ATC code ?
Chemical data
Formula C12H17NO 
Mol. mass 191.27

6-MAPDB (1-(2,3-dihydrobenzofuran-6-yl)-N-methylpropan-2-amine) is a chemical compound which might be an entactogenic drug. It is structurally related to drugs like 6-APDB and 6-MAPB, which have similar effects to MDMA and have been used as recreational drugs. 6-MAPDB has never been studied to determine its pharmacological activity, though it is the N-methyl derivative of 6-APDB which is known to be a selective serotonin releaser.[1]

Legality[edit]

6-MAPDB was banned in the UK in June 2013 as a temporary class drug along with 9 other related compounds, despite having never been sold as a street drug itself. This was due to concerns that it would have similar effects to drugs such as 6-APB that had been widely sold already, and 6-MAPDB might therefore be likely to become used recreationally also, if it were not banned preemptively.[2]

See also[edit]

References[edit]

  1. ^ Monte AP, Marona-Lewicka D, Cozzi NV, Nichols DE (November 1993). "Synthesis and pharmacological examination of benzofuran, indan, and tetralin analogues of 3,4-(methylenedioxy)amphetamine". Journal of Medicinal Chemistry 36 (23): 3700–6. doi:10.1021/jm00075a027. PMID 8246240. 
  2. ^ "Temporary class drug order report on 5-6APB and NBOMe compounds". UK Home Office. 4 Jun 2013. Retrieved 2013-07-11.